The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy
Open accessAbstract
The absence of tumor antigens leads to a low response rate, which represents a major challenge in immune checkpoint blockade (ICB) therapy. Pyroptosis, which releases tumor antigens and damage‐associated molecular patterns (DAMPs) that induce antitumor immunity and boost ICB efficiency, potentially leads to injury when occurring in normal tissues. Therefore, a strategy and highly efficient agent to induce tumor‐specific pyroptosis but reduce pyroptosis in normal tissues is urgently required. Here, a smart tumor microenvironmental reactive oxygen species (ROS)/glutathione (GSH) dual‐responsive nano‐prodrug (denoted as MCPP) with high paclitaxel (PTX) and photosensitizer purpurin 18 (P18) loading is rationally designed. The ROS/GSH dual‐responsive system facilitates the nano‐prodrug response to high ROS/GSH in the tumor microenvironment and achieves optimal drug release in tumors. ROS generated by P18 after laser irradiation achieves controlled release and induces tumor cell pyroptosis with PTX by chemo‐photodynamic therapy. Pyroptotic tumor cells release DAMPs, thus initiating adaptive immunity, boosting ICB efficiency, achieving tumor regression, generating immunological memory, and preventing tumor recurrence. Mechanistically, chemo‐photodynamic therapy and control‐release PTX synergistically induce gasdermin E (GSDME)‐related pyroptosis. It is speculated that inspired chemo‐photodynamic therapy using the presented nano‐prodrug strategy can be a smart strategy to trigger pyroptosis and augment ICB efficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Hugo, W., Zaretsky, J. M., Sun, L., Song, C., Moreno, B. H., Hu-Lieskovan, S., Berent-Maoz, B., Pang, J., Chmielowski, B., Cherry, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.065 · Cited by 3,448
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
Wang, Y., Gao, W., Shi, X., Ding, J., Liu, W., He, H., Wang, K., & Shao, F. (2017) · Nature · doi:10.1038/nature22393 · Cited by 3,199
Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
Shi, J., Gao, W., & Shao, F. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.10.004 · Cited by 3,088
Cancer immunoediting and resistance to T cell-based immunotherapy
O’Donnell, J. S., Teng, M. W. L., & Smyth, M. J. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0142-8 · Cited by 1,759
Gasdermin E suppresses tumour growth by activating anti-tumour immunity
Zhang, Z., Zhang, Y., Xia, S., Kong, Q., Li, S., Liu, X., Junqueira, C., Meza-Sosa, K. F., Mok, T. M. Y., Ansara, J., et al. (2020) · Nature · doi:10.1038/s41586-020-2071-9 · Cited by 1,686
The gasdermins, a protein family executing cell death and inflammation
Broz, P., Pelegrín, P., & Shao, F. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0228-2 · Cited by 1,641
Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells
Zhou, Z., He, H., Wang, K., Shi, X., Wang, Y., Su, Y., Wang, Y., Li, D., Liu, W., Zhang, Y., et al. (2020) · Science · doi:10.1126/science.aaz7548 · Cited by 1,317
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Tang, R., Xu, J., Zhang, B., Liu, J., Liang, C., Hua, J., Meng, Q., Yu, X., & Shi, S. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00946-7 · Cited by 1,273
Broz, M. L., Binnewies, M., Boldajipour, B., Nelson, A. E., Pollack, J. L., Erle, D. J., Barczak, A., Rosenblum, M. D., Daud, A., Barber, D. L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.007 · Cited by 1,207
Immunogenic and tolerogenic cell death
Green, D. R., Ferguson, T., Zitvogel, L., & Kroemer, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2545 · Cited by 1,176
A bioorthogonal system reveals antitumour immune function of pyroptosis
Wang, Q., Wang, Y., Ding, J., Wang, C., Zhou, X., Gao, W., Huang, H., Shao, F., & Liu, Z. (2020) · Nature · doi:10.1038/s41586-020-2079-1 · Cited by 1,083
Structural Mechanism for GSDMD Targeting by Autoprocessed Caspases in Pyroptosis
Wang, K., Sun, Q., Zhong, X., Zeng, M., Zeng, H., Shi, X., Li, Z., Wang, Y., Zhao, Q., Shao, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.002 · Cited by 750
Gaul, S., Leszczynska, A., Alegre, F., Kaufmann, B., Johnson, C. D., Adams, L. A., Wree, A., Damm, G., Seehofer, D., Calvente, C. J., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.041 · Cited by 552
GSH‐Depleted PtCu3 Nanocages for Chemodynamic‐ Enhanced Sonodynamic Cancer Therapy
Zhong, X., Wang, X., Cheng, L., Tang, Y., Zhan, G., Gong, F., Zhang, R., Hu, J., Liu, Z., & Yang, X. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201907954 · Cited by 541
A Mitochondria‐Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects Under Hypoxia
Lv, W., Zhang, Z., Zhang, K. Y., Yang, H., Liu, S., Xu, A., Guo, S., Zhao, Q., & Huang, W. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201604130 · Cited by 523
ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy
Xu, X., Saw, P. E., Tao, W., Li, Y., Ji, X., Bhasin, S., Liu, Y., Ayyash, D., Rasmussen, J., Huo, M., et al. (2017) · Advanced Materials · doi:10.1002/adma.201700141 · Cited by 499
Stimuli‐Responsive Materials for Controlled Release of Theranostic Agents
Wang, Y., Shim, M. S., Levinson, N. S., Sung, H., & Xia, Y. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201400279 · Cited by 378
Inflammation‐Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti‐PD1 Antibody
Wang, C., Sun, W., Wright, G., Wang, A. Z., & Gu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201506312 · Cited by 344
Wu, M., Liu, X., Chen, H., Duan, Y., Liu, J., Pan, Y., & Liu, B. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202016399 · Cited by 315
Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy
Li, M., Li, S., Zhou, H., Tang, X., Wu, Y., Jiang, W., Tian, Z., Zhou, X., Yang, X., & Wang, Y. (2020) · Nature Communications · doi:10.1038/s41467-020-14963-0 · Cited by 300
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
Guo, Z. S., Liu, Z., & Bartlett, D. L. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00074 · Cited by 284
Watchmaker, P. B., Lahl, K., Lee, M., Baumjohann, D., Morton, J., Kim, S. J., Zeng, R., Dent, A., Ansel, K. M., Diamond, B., et al. (2014) · Nature Immunology · doi:10.1038/ni.2768 · Cited by 266
Switching from Apoptosis to Pyroptosis: Gasdermin-Elicited Inflammation and Antitumor Immunity
Tsuchiya, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010426 · Cited by 255
Wu, D., Wang, S., Yu, G., & Chen, X. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202010281 · Cited by 228
Liu, Y., Zhen, W., Wang, Y., Song, S., & Zhang, H. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c09482 · Cited by 225
Ma, S., Song, W., Xu, Y., Si, X., Lv, S., Zhang, Y., Tang, Z., & Chen, X. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b05265 · Cited by 178
Cheng, H., Zheng, R.-R., Fan, G.-L., Fan, J.-H., Zhao, L.-P., Jiang, X.-Y., Yang, B., Yu, X.-Y., Li, S.-Y., & Zhang, X.-Z. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.005 · Cited by 171
Ji, X., Kang, Y., Ouyang, J., Chen, Y., Artzi, D., Zeng, X., Xiao, Y., Feng, C., Qi, B., Kim, N. Y., et al. (2019) · Advanced Science · doi:10.1002/advs.201901211 · Cited by 165
Self-citationLi, J., Anraku, Y., & Kataoka, K. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004180 · Cited by 142
Enzyme-Driven Membrane-Targeted Chimeric Peptide for Enhanced Tumor Photodynamic Immunotherapy
Zhang, C., Gao, F., Wu, W., Qiu, W., Zhang, L., Li, R., Zhuang, Z., Yu, W., Cheng, H. L., & Zhang, X. (2019) · ACS Nano · doi:10.1021/acsnano.9b04315 · Cited by 136
Yang, X., Hu, C., Tong, F., Liu, R., Zhou, Y., Qin, L., Ouyang, L., & Gao, H. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201901896 · Cited by 111
Role of pyroptosis in liver diseases
Mamun, A. A., Wu, Y., Jia, C., Munir, F., Sathy, K. J., Sarker, T., Monalisa, I., Zhou, K., & Xiao, J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106489 · Cited by 93
Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells
Kumar, P., Saini, S., Khan, S. M., Lele, S. S., & Prabhakar, B. S. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.09.008 · Cited by 77
Zhao, Y., Ji, T., Wang, H., Li, S., Zhao, Y., & Nie, G. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.037 · Cited by 70
Mao, L., Zhao, Z., Yu, G., Wu, L., Deng, W., Li, Y., Liu, J., Bu, L., Liu, B., Kulkarni, A. B., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31115 · Cited by 70
Self-citationZhao, H., Song, Q., Zheng, C., Zhao, B., Wu, L., Feng, Q., Zhang, Z., & Wang, L. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202005747 · Cited by 69
Grimaldi, A., Cammarata, I., Martire, C., Focaccetti, C., Piconese, S., Buccilli, M., Mancone, C., Buzzacchino, F., Berrìos, J. R. G., D’Alessandris, N., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-0811-x · Cited by 53
Ma, X., Zhang, T., Qiu, W., Liang, M., Gao, Y., Xue, P., Kang, Y., & Xu, Z. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.127657 · Cited by 49
Self-citationWu, D., Wang, S., Yu, G., & Chen, X. S. (2020) · Angewandte Chemie · doi:10.1002/ange.202010281 · Cited by 45
Zhao, Q., Zhu, H.-P., Xie, X., Mao, Q., Liu, Y., He, X., Peng, C. Y., Jiang, Q., & Huang, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051845 · Cited by 37
Wang, C., Ding, Y., Liu, Y., Zhang, Q., Xu, S., Xia, L., Duan, H., Wang, S., Ji, P., Huang, W., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.576603 · Cited by 12
Cited by
Pyroptosis in inflammatory diseases and cancer
Rao, Z., Zhu, Y., Yang, P., Chen, Z., Xia, Y., Qiao, C., Liu, W., Deng, H., Li, J., Ning, P., et al. (2022) · Theranostics · doi:10.7150/thno.71086 · Cited by 800
Targeting ROS in cancer: rationale and strategies
Glorieux, C., Liu, S., Trachootham, D., & Huang, P. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00979-4 · Cited by 651
Theranostic Fluorescent Probes
Sharma, A., Verwilst, P., Li, M., Ma, D., Singh, N., Yoo, J., Kim, Y., Yang, Y., Zhu, J.-H., Huang, H., et al. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00778 · Cited by 499
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Lu, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Canadas, I., Tian, Y., Niu, X., Wang, Y., Torabian, P., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01535-8 · Cited by 373
ZIF‐8 Nanoparticles Evoke Pyroptosis for High‐Efficiency Cancer Immunotherapy
Ding, B., Chen, H., Tan, J., Meng, Q., Zheng, P., Ma, P., & Lin, J. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202215307 · Cited by 348
Metadata
- Authors
- Xiao, Y., Zhang, T., Ma, X., Yang, Q., Yang, L., Yang, S., Liang, M., Xu, Z., & Sun, Z.
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2021-10-27
- Volume
- 8
- Issue
- 24
- Pages
- e2101840-e2101840
- ISSN
- 2198-3844 (ISSN-L)
- OpenAlex
- W3208991717
- Cited by
- 325
- References
- 44
- FWCI
- 17.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.